“Golden Root” Shut DOWN Arthritis Inflammation in 71% of Patients?

It’s a Chinese breakthrough that’s already delivering REAL relief for rheumatoid arthritis patients…

But it’s practically unknown in America.

If you or someone you love is suffering from rheumatoid arthritis, you know how it takes over your life.

The morning stiffness gets so bad that getting out of bed in the morning can seem impossible.

Just opening a jar can leave your hands in agony.

And the drugs mainstream medicine uses for rheumatoid arthritis can shut down your immune system, leaving you a sitting duck for every infection out there.

But in China, healers have discovered a powerful “golden root” that has helped calm some of the worst symptoms in an impressive 71% of rheumatoid arthritis patients.

And it could hold the key to giving you your independence back.

The golden root is called Scutellaria baicalensis. But in traditional Chinese medicine, it’s known as Huang Qin.

Huang Qin has an active compound called baicalin that’s really turning heads in the arthritis research community.

For centuries, Chinese healers used Huanq Qin for what they called “heat” and “swelling” in the joints. Western medicine dismissed it as folklore—until researchers started testing the baicalin from Huang Qin in rheumatoid arthritis patients.

A clinical trial published in Lipids in Health and Disease enrolled 374 patients with both rheumatoid arthritis and heart disease. Half received 500 mg of baicalin daily for 12 weeks – the other half got a placebo.

At the end, a whopping 71% of baicalin patients reported real improvement according to EULAR criteria—the standard European measure for arthritis symptoms.

That’s not a marginal difference. That’s real relief.

The study also measured hs-CRP—high-sensitivity C-reactive protein, the blood marker for inflammation. Baicalin patients dropped by more than HALF, from 3.9 mg/dL to 1.64 mg/dL.

Inflammation didn’t just feel better. It measured better.

Animal studies show what’s happening inside inflamed joints.

Using collagen-induced arthritis in mice and rats—the gold standard model—baicalin significantly reduced ankle swelling, joint destruction, and bone erosion. X-rays confirmed less bone damage in treated animals.

Studies also measured inflammatory chemicals flooding arthritic joints: TNF-α, IL-6, IL-17, and IL-1β.

Baicalin lowered all of them significantly.

Here’s what that means for you…

With rheumatoid arthritis, your immune system attacks your joints like they’re foreign invaders. It sends inflammatory signals that cause swelling and pain, and eventually destroy cartilage and bone.

Baicalin blocks NF-κB—the master inflammation switch. It reduces the chemical messengers that recruit inflammatory cells. And it helps prevent immune cells from going into overdrive.

Less swelling. Less pain. Less joint destruction.

Look for Scutellaria baicalensis root extract standardized for baicalin content. The human trial used 500 mg daily. Some combination formulas go up to 1,000 mg, but higher doses are less studied.

Most people take it once daily with food.

Seventy-one percent improvement. Real patients. Twelve weeks.

Just one caution if you want to try it yourself: If you’re on blood thinners or immunosuppressant drugs, check with your doctor before starting. Baicalin may interact with certain medications.

To less pain and better movement,

Rachel Mace
Managing Editorial Director, e-Alert
with contributions from the research team

Sources:

• Hang, Y., Qin, X., Ren, T., & Cao, J. (2018). Baicalin reduces blood lipids and inflammation in patients with coronary artery disease and rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial. Lipids in Health and Disease, 17(1), 146. https://lipidworld.biomedcentral.com/articles/10.1186/s12944-018-0797-2
• Chen, H., Gao, Y., Wu, J., Chen, Y., Chen, B., Hu, J., & Zhou, J. (2013). Baicalin inhibits IL-17-mediated joint inflammation in murine adjuvant-induced arthritis. Clinical and Developmental Immunology, 2013, 268065. https://pubmed.ncbi.nlm.nih.gov/23840239/
• Bai, L., Nong, Y., Shi, Y., Liu, M., Yan, L., Shang, J., Huang, L., & Shi, Y. (2020). Baicalin alleviates collagen‑induced arthritis and suppresses TLR2/MYD88/NF‑κB p65 signaling in rats and HFLS‑RAs. Molecular Medicine Reports, 22(4), 2833-2841. https://pubmed.ncbi.nlm.nih.gov/32945496/
• Chen, X., Wu, Y., Yang, T., Wei, M., Wang, Y., Deng, X., Sun, Z., Han, B., & Zeng, Y. (2019). Baicalin attenuates collagen-induced arthritis via inhibition of JAK2-STAT3 signaling and regulation of Th17 cells in mice. Annals of Translational Medicine, 7(4), 80. https://pmc.ncbi.nlm.nih.gov/articles/PMC6381382/
• Ding, Y., Li, Q., Xu, Y., Chen, Y., Deng, Y., Zhi, F., & Qian, K. (2016). Baicalin ameliorates collagen-induced arthritis through the suppression of Janus Kinase 1 (JAK1)/signal transducer and activator of transcription 3 (STAT3) signaling in mice. Pharmaceutical Biology, 54(12), 2957-2966. https://pubmed.ncbi.nlm.nih.gov/27251892/
• Liu, Y., Zhou, Y., Li, N., Zhang, Y., & Li, Y. (2022). Anti-inflammatory effect of baicalin in rats with adjuvant arthritis and its autophagy-related mechanism. Frontiers in Pharmacology, 13, 810823. https://pubmed.ncbi.nlm.nih.gov/35124596/